TheProfitWatch

CDTX - Cidara Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
219.35 0.05 (0.02%) -0.02 (-0.01%) -0.13 (-0.06%) 0.07 (0.03%) 0.39 (0.18%) -0.05 (-0.02%) --- 0.39 (0.18%)

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.65
Diluted EPS:
-1.65
Basic P/E:
-132.9697
Diluted P/E:
-132.9697
RSI(14) 1m:
66.67
VWAP:
219.4
RVol:

Events

Period Kind Movement Occurred At

Related News